Advertisement

A history of preeclampsia identifies women who have underlying cardiovascular risk factors

Published:August 11, 2008DOI:https://doi.org/10.1016/j.ajog.2008.06.035

      Objective

      The objective of this study was to prospectively assess physical and biochemical cardiovascular risk markers in women who had developed preeclampsia (PE) at 1 year postpartum.

      Study Design

      Following an overnight fast, previously PE (n = 70) and normotensive women (n = 70) had weight and blood pressure recorded and levels of morning blood for insulin, glucose, C-reactive protein, lipids, cholesterol, and urine for microalbumin and creatinine measured. Body mass index, homeostatic model assessment index, and incidence of metabolic syndrome were determined.

      Results

      At 1 year postpartum, markers of cardiovascular disease were different between the groups. There were also differences in the number of women with abnormal values. Mathematical modeling of cardiovascular event risk suggests that PE increases the risk by 2- to 3-fold; the risk was greatest for women with severe PE.

      Conclusion

      The development of PE is 1 of the earliest clinically identifiable markers of a woman's heightened risk of cardiovascular disease.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Smith G.C.S.
        • Pell J.P.
        • Walsh D.
        Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.
        Lancet. 2001; 357: 2002-2006
        • Ray J.G.
        • Vermeulen M.J.
        • Schull M.J.
        • Redelmeier D.A.
        Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.
        Lancet. 2005; 366: 1797-1803
        • Funai E.F.
        • Paltiel O.B.
        • Malaspina D.
        • Friedlander Y.
        • Deutsch L.
        • Harlap S.
        Risk factors for pre-eclampsia in nulliparous and parous women: the Jerusalem Perinatal Study.
        Paediatr Perinat Epidemiol. 2005; 19: 59-68
        • Manten G.T.R.
        • Sikkema M.J.
        • Voorbij H.A.M.
        • Visser G.H.A.
        • Bruinse H.W.
        • Franx A.
        Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction.
        Hypertens Pregnancy. 2007; 26: 39-50
        • Forest J.-C.
        • Girouard J.
        • Masse J.
        • et al.
        Early occurrence of metabolic syndrome after hypertension in pregnancy.
        Obstet Gynecol. 2005; 105: 1373-1380
        • Rodie V.A.
        • Freeman D.J.
        • Sattar N.
        • Greer I.A.
        Pre-eclampsia and cardiovascular disease: metabolic syndrome in pregnancy?.
        Atherosclerosis. 2004; 175: 189-202
      1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Bar J.
        • Kaplan B.
        • Wittenberg C.
        • et al.
        Microalbuminuria after pregnancy complicated by pre-eclampsia.
        Nephrol Dial Transplant. 1999; 14: 1129-1132
        • North R.A.
        • Simmons D.
        • Barnfather D.
        • Upjohn M.
        What happens to women with preeclampsia?.
        Aust N Z J Obstet Gynaecol. 1996; 36: 233-238
        • Agrawal B.
        • Berger A.
        • Wolf K.
        • Luft F.C.
        Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension.
        J Hypertens. 1996; 14: 223-228
        • Bianchi S.
        • Bigazzi R.
        • Campese V.M.
        Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.
        Am J Kidney Dis. 1999; 34: 973-995
        • Deckert T.
        • Feldt-Rasmussen B.
        • Borch-Johnsen K.
        • Jensen T.
        • Kofoed-Enevoldsen A.
        Albuminuria reflects widespread vascular damage: the Steno hypothesis.
        Diabetologia. 1989; 32: 219-226
        • Jensen J.S.
        • Feldt-Rasmussen B.
        • Strandgaard S.
        • Schroll M.
        • Borch-Johnsen K.
        Arterial hypertension, microalbuminuria, and risk of ischemic heart disease.
        Hypertension. 2000; 35: 898-903
        • Agatisa P.K.
        • Ness R.B.
        • Roberts J.M.
        • Costantino J.P.
        • Kuller L.H.
        • McLaughlin M.K.
        Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.
        Am J Physiol Circ Physiol. 2004; 286: H1389-H1393
        • Lampinen K.
        • Ronnback M.
        • Kaaja R.
        • Groop P.-H.
        Impaired vascular dilation in women with a history of pre-eclampsia.
        J Hypertens. 2006; 24: 751-756
      2. ACOG Practice Bulletin: diagnosis and management of preeclampsia and eclampsia.
        Obstet Gynecol. 2002; 99: 159-167
        • Helewa M.E.
        • Burrows R.
        • Smith J.
        • Williams K.
        • Brain P.
        • Rabkin S.W.
        Report of the Canadian Hypertension Society Consensus Conference: 1.
        CMAJ. 1997; 157: 715-725
        • O'Brien E.
        • Asmar R.
        • Beilin L.
        • Imai Y.
        • Mallion J.
        European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement.
        J Hypertens. 2003; 21: 821-848
        • Brown M.A.
        • McHugh L.
        • Mangos G.
        • Davis G.
        Automated self-initiated blood pressure or 24-hour ambulatory blood pressure monitoring in pregnancy.
        Br J Obstet Gynaecol. 2004; 111: 38-41
        • Beckett L.
        • Godwin M.
        The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension.
        BMC Cardiovasc Disord. 2005; 5: 18
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        • Turner R.C.
        Homeostatic model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Romero-Gutierrez G.
        • Malacara J.M.
        • Amador N.
        • Fierro-Martinez C.
        • Munoz-Guivara L.M.
        • Molina-Rodriguez R.
        Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study.
        Am J Perinatol. 2004; 21: 455-462
        • World Health Organization (WHO)
        Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: diagnosis and classification of diabetes mellitus.
        World Health Organization, Geneva (Switzerland)1999
        • American Diabetes Association
        Standards of medical care in diabetes.
        Diabetes Care. 2004; 27: S15-S35
        • Cook N.R.
        • Buring J.E.
        • Ridker P.M.
        The effect of including C-reactive protein in cardiovascular risk prediction models for women.
        Ann Intern Med. 2006; 145: 21-29
        • National Heart, Lung, and Blood Institute
        Report of the Working Group on Research on Hypertension During Pregnancy.
        National Heart, Lung, and Blood Institute, Bethesda (MD)2001
        • Roberts J.M.
        • Gammill H.
        Insulin resistance in preeclampsia.
        Hypertension. 2006; 47: 341-342
        • Magnussen E.B.
        • Vatten L.J.
        • Lund-Nilsen T.I.
        • Salvesen K.A.
        • Smith G.D.
        • Romundstad P.R.
        Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study.
        BMJ. 2007; 335: 978
        • Sabour S.
        • Franx A.
        • Rutten A.
        • et al.
        High blood pressure in pregnancy and coronary calcification.
        Hypertension. 2007; 49: 1-5
        • Bellamy L.
        • Casas J.P.
        • Hingorani A.D.
        • Williams D.J.
        Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systemic review and meta-analysis.
        BMJ. 2007; 335: 974
        • Sattar N.
        • Greer I.A.
        Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?.
        BMJ. 2002; 325: 157-160
        • Irgens H.U.
        • Reisaeter L.
        • Lie R.T.
        Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.
        BMJ. 2001; 323: 1213-1217
        • Nishimoto K.
        • Shiiki H.
        • Nishino T.
        • et al.
        Glomerular hypertrophy in preeclamptic patients with focal segmental glomerulosclerosis.
        Clin Nephrol. 1999; 51: 209-219
        • Packham D.K.
        • Mathews D.C.
        • Fairley K.F.
        • Whitworth J.A.
        • Kincaid-Smith P.
        Morphometric analysis of pre-eclampsia in women biopsied in pregnancy and post-partum.
        Kidney Int. 1988; 34: 704-711
        • Shiiki H.
        • Dohi K.
        • Hanatani M.
        • et al.
        Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome.
        Am J Nephrol. 1990; 10: 205-212
        • Lee H.S.
        • Kim T.S.
        A morphometric study of preeclamptic nephropathy with focal segmental glomerulosclerosis.
        Clin Nephrol. 1995; 44: 14-21
        • Nochy D.
        • Heudes D.
        • Glotz D.
        • et al.
        Preeclampsia associated focal and segmental glomerulosclerosis and glomerular hypertrophy: a morphometric analysis.
        Clin Nephrol. 1994; 42: 9-17
        • Thomas G.N.
        • Ho S.-Y.
        • Janus E.D.
        • et al.
        The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population.
        Diabetes Res Clin Pract. 2005; 67: 251-257
        • Wolf M.
        • Hubel C.A.
        • Lam C.
        • et al.
        Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.
        J Clin Endocrinol Metab. 2004; 89: 6239-6243
        • Nardi O.
        • Zureik M.
        • Courbon D.
        • Ducimetiere P.
        • Clavel-Chapelon F.
        Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study.
        Eur J Cardiovasc Prev Rehabil. 2006; 13: 281-283
        • Catov J.M.
        • Newman A.B.
        • Roberts J.M.
        • et al.
        Preterm delivery and later maternal cardiovascular disease risk.
        Epidemiology. 2007; 18: 733-739
        • Isomaa B.
        • Almgren P.
        • Tuomi T.
        • et al.
        Cardiovascular morbidity and mortality associated with the metabolic syndrome.
        Diabetes Care. 2001; 24: 690-694
        • Ridker P.M.
        • Buring J.E.
        • Cook N.R.
        • Rifai N.
        C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women.
        Circulation. 2003; 107: 391-397
        • Stehouwer C.D.A.
        • Gall M.-A.
        • Twisk J.W.R.
        • Knudsen E.
        • Emeis J.J.
        • Parving H.-H.
        Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.
        Diabetes. 2002; 51: 1157-1165
        • Roberts J.M.
        • Gammill H.
        Pre-eclampsia and cardiovascular disease in later life.
        Lancet. 2005; 366: 961-962
        • Levenson J.W.
        • Skerrett P.J.
        • Gaziano M.
        Reducing the global burden of cardiovascular disease: the role of risk factors.
        Prev Cardiol. 2002; 5: 188-199